Denali Therapeutics shares owned by Groupama Asset Managment
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Groupama Asset Managment
from 13F filings
Historical chart of Groupama Asset Managment investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by Groupama Asset Managment
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $899k | 44k | 20.52 |
2023-12-31 | $752k | 35k | 21.47 |